Opinion: What the History of Blood Transfusion Reveals About Risk

Every medical intervention—even one with a centuries-long history—brings dangers, some of which become clear only later.

| 5 min read
Human blood in a plastic Intravenous drip bag, the tube running out of the image. Square crop. Horizontal with copy space.

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM, RYANJLANE

When making decisions about medical procedures, we yearn for complete information about the risks and benefits. Unfortunately, we will never know everything. The question is, when do we know enough to be reasonably assured that undergoing a particular procedure or taking a particular drug is worth the risk? Consider blood transfusions, for example. When would you have deemed blood transfusions safe enough to consent to one?

We’ll start at the beginning.

In 1665, Richard Lower solved a fundamental problem of blood transfusions: clotting. Once exposed to air, blood quickly clots, making it impossible to transfuse. After draining large quantities of blood from a dog and causing it to go into shock, Lower’s solution was to use a series of tubes to connect an artery from a healthy dog to a vein of the dying dog. It worked, saving the dog’s life.

Two years later, four blood ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Paul A. Offit

    Paul A. Offit is a professor of pediatrics at the Children’s Hospital of Philadelphia.

Published In

Online only cover of the The Scientist, September 2021 issue
September 2021

Mapping Covid

SARS-COV-2 wreaks havoc around the body

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours